Overview

C-Reactive Protein (CRP) in Obese Diabetic Women

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether treatment with rosuvastatin for 6 months in obese type 2 diabetic women will improve their lipid profiles and thus prevent the progression to cardiovascular disease.

Phase:

Phase 4

Details

Lead Sponsor:

AstraZeneca

Collaborator:

Mexican National Institute of Public Health

Treatments:

Rosuvastatin Calcium